Stockreport

Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn's and Colitis Organisation [Yahoo! Finance]

Spyre Therapeutics, Inc.  (SYRE) 
PDF company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease ("IBD") an [Read more]